Production (Stage)
Spectral Medical Inc.
EDTXF
$0.614
$0.0040.66%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -19.56% | 71.75% | 24.36% | 51.10% | 26.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.56% | 71.75% | 24.36% | 51.10% | 26.47% |
| Cost of Revenue | -32.78% | 24.41% | 5.45% | 35.56% | 173.15% |
| Gross Profit | -2.88% | 138.74% | 87.03% | 226.34% | -24.71% |
| SG&A Expenses | 53.74% | -9.98% | 4.09% | 5.44% | 29.16% |
| Depreciation & Amortization | -63.98% | 53.76% | 10.35% | 423.08% | 76.05% |
| Other Operating Expenses | 561.80% | 49.74% | -49.92% | -- | 57.00% |
| Total Operating Expenses | 40.35% | -6.52% | -0.69% | 19.49% | 41.78% |
| Operating Income | -59.12% | 16.35% | 3.95% | -16.91% | -47.38% |
| Income Before Tax | -184.79% | 147.60% | -167.46% | -0.78% | -280.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -184.79% | 147.60% | -167.46% | -0.78% | -280.84% |
| Earnings from Discontinued Operations | 4.55% | 86.88% | -- | -- | 93.08% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -184.64% | 147.32% | -158.33% | -1.95% | -266.72% |
| EBIT | -59.12% | 16.35% | 3.95% | -16.91% | -47.38% |
| EBITDA | -60.18% | 17.13% | 3.81% | -17.04% | -48.83% |
| EPS Basic | -180.00% | 146.20% | -154.90% | -1.77% | -266.67% |
| Normalized Basic EPS | -179.71% | 152.08% | -167.21% | 0.00% | -283.33% |
| EPS Diluted | -180.00% | 146.20% | -154.90% | -1.77% | -266.67% |
| Normalized Diluted EPS | -179.71% | 152.08% | -167.21% | 0.00% | -283.33% |
| Average Basic Shares Outstanding | 1.89% | 1.78% | 1.11% | 0.54% | 0.33% |
| Average Diluted Shares Outstanding | 1.89% | 1.78% | 1.11% | 0.54% | 0.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |